Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Works of Marcel Nijland being referenced
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
2019
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marcel Nijland | 686 | 508 | 270 | 328 | 89 | 987 | |
| Alina S. Gerrie | 758 | 440 | 393 | 251 | 107 | 1.0k | |
| Alice Di Rocco | 750 | 456 | 263 | 307 | 60 | 1.0k | |
| Reem Karmali | 627 | 539 | 186 | 241 | 109 | 995 | |
| Beth Christian | 654 | 502 | 386 | 169 | 79 | 931 | |
| Biljana Mihaljević | 672 | 414 | 272 | 161 | 101 | 1.1k | |
| David Belada | 770 | 564 | 309 | 162 | 160 | 993 | |
| Adam M. Petrich | 538 | 380 | 218 | 164 | 57 | 879 | |
| Vincenzo Pavone | 603 | 451 | 255 | 245 | 60 | 1.1k | |
| Maria Cantonetti | 557 | 370 | 302 | 200 | 83 | 1.2k | |
| Paul J. Bröckelmann | 621 | 494 | 120 | 226 | 82 | 890 |
All Works
Login with ORCID to disown or claim papers
Loading papers...